![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Wednesday, February 03, 2021 12:19:32 PM
Fundamentally flawed USRM has no direction in the arena of stem cells other than they may have done some research back in the day. Maybe the initials should stand for U.S. Regenerative Medicine. They’ve lost their grip on the stem cell market, so they’re throwing in procedures like laser therapy and NAD injections which are not for low, mid or large cap companies.. cause there’s no large market. No plan exists to turn this company a profit and the accountants just keep slapping on that ‘going concern’ in every audit.
Last Shot Hydration Drink Announced as Official Sponsor of Red River Athletic Conference • EQLB • Jun 20, 2024 2:38 PM
ATWEC Announces Major Acquisition and Lays Out Strategic Growth Plans • ATWT • Jun 20, 2024 7:09 AM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM